What's in Johnson & Johnson Taiwan Ltd's pipeline?

Johnson & Johnson Taiwan Ltd has 5 drugs in our index: 5 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Johnson & Johnson Taiwan Ltd's portfolio?

Top competitors by shared drug class: Janssen Korea, Ltd., Korea, Albert Einstein College of Medicine, Henry Ford Health System, Children's Hospitals and Clinics of Minnesota, Daewon Pharmaceutical Co., Ltd..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/johnson-johnson-taiwan-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Johnson & Johnson Taiwan Ltd — Portfolio Competitive Intelligence Brief

Johnson & Johnson Taiwan Ltd pipeline: 5 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

5 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Fentanyl transdermal therapeutic system	Fentanyl transdermal therapeutic system	marketed
Risperidone immediate-release	Risperidone immediate-release	marketed
Topiramate add-on therapy	Topiramate add-on therapy	marketed
Tramadol /acetaminophen	Tramadol /acetaminophen	marketed	Opioid analgesic combination	Mu opioid receptor; norepinephrine transporter; serotonin transporter; cyclooxygenase	Pain Management
Topiramate monotherapy	Topiramate monotherapy	marketed	Anticonvulsant / Antiepileptic agent	GABA-A receptor; voltage-gated sodium channels	Neurology

Therapeutic area mix

Neurology · 1
Pain Management · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Janssen Korea, Ltd., Korea · 2 shared drug classes
Albert Einstein College of Medicine · 1 shared drug class
Henry Ford Health System · 1 shared drug class
Children's Hospitals and Clinics of Minnesota · 1 shared drug class
Daewon Pharmaceutical Co., Ltd. · 1 shared drug class
Eisai Korea Inc. · 1 shared drug class
Barrie Urology Associates · 1 shared drug class
Albany Medical College · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Johnson & Johnson Taiwan Ltd:

Cite this brief

Drug Landscape (2026). Johnson & Johnson Taiwan Ltd — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/johnson-johnson-taiwan-ltd. Accessed 2026-05-16.